Optimising Intratumoral Treatment of Head and Neck Squamous Cell Carcinoma Models With the Diterpene Ester Tigilanol Tiglate

Investigational New Drugs - Netherlands
doi 10.1007/s10637-018-0604-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Head and Neck Squamous Cell Carcinoma in Pregnant Women

Laryngoscope
Otorhinolaryngology
2011English

Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma

Practical Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Successful Treatment of Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck Using Pembrolizumab

Opuholi Golovy i Sei
OncologyRadiologyPharmacologyCancer ResearchNuclear MedicineOtorhinolaryngologyImagingSurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy